RiverFront Investment Group LLC Sells 4,777 Shares of Stryker Corporation $SYK

RiverFront Investment Group LLC lessened its position in Stryker Corporation (NYSE:SYK) by 35.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 8,719 shares of the medical technology company’s stock after selling 4,777 shares during the period. RiverFront Investment Group LLC’s holdings in Stryker were worth $3,065,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of SYK. United Financial Planning Group LLC bought a new position in shares of Stryker in the 3rd quarter valued at about $27,000. CGC Financial Services LLC bought a new position in shares of Stryker in the 4th quarter valued at about $29,000. Strive Asset Management LLC bought a new position in shares of Stryker in the 3rd quarter valued at about $30,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Stryker in the 3rd quarter valued at about $34,000. Finally, Copia Wealth Management grew its position in shares of Stryker by 181.6% in the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after acquiring an additional 69 shares during the period. Institutional investors own 77.09% of the company’s stock.

Stryker Stock Performance

NYSE SYK opened at $306.74 on Monday. The firm has a 50-day moving average of $329.68 and a 200-day moving average of $351.50. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The stock has a market cap of $117.59 billion, a PE ratio of 35.50, a P/E/G ratio of 1.93 and a beta of 0.80. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, sell-side analysts anticipate that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Needham & Company LLC decreased their price objective on shares of Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Leerink Partners assumed coverage on shares of Stryker in a research report on Monday, April 13th. They issued an “outperform” rating and a $410.00 price objective for the company. Jefferies Financial Group reissued a “buy” rating and issued a $465.00 price objective on shares of Stryker in a research report on Wednesday, March 4th. Sanford C. Bernstein set a $410.00 price objective on shares of Stryker in a research report on Friday, May 1st. Finally, Wells Fargo & Company decreased their price objective on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $395.48.

Insider Activity

In other Stryker news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president owned 177 shares in the company, valued at $50,170.65. The trade was a 95.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 4.60% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.